TrialFrontiers in public health2022

Development and Validation of a Competitive Risk Model in Elderly Patients With Chromophobe Cell Renal Carcinoma: A Population-Based Study.

Jinkui Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.